Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
The New Phytologist|January 16, 2024
Rapid in situ diversification rates in Rhamnaceae explain the parallel evolution of high diversity in temperate biomes from global to local scalesQin Tian, Gregory W Stull, Jürgen Kellermann, et al.
Brain Imaging and Behavior|October 13, 2016
Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptomsZora Kikinis, Kang Ik K Cho, Ioana L Coman, et al.
Plant Diversity|August 1, 2026
Phylogenomic conflict in Moraceae: Evidence for pervasive introgression and incomplete lineage sortingChen-Xuan Yang, Shui-Yin Liu, Qin Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimenE Warner, D Hedley, I Andrulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2008
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trialO Gluz, U A Nitz, N Harbeck, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
The distinct roles of MSH2 and MLH1 in basal-like breast cancer and immune modulationTanzia Islam Tithi, Jiao Mo, Nicholas Borcherding, et al.
Nature Communications|May 27, 2024
Shifts in evolutionary lability underlie independent gains and losses of root-nodule symbiosis in a single clade of plantsHeather R Kates, Brian C O'Meara, Raphael LaFrance, et al.
Plant Diversity|January 15, 2025
Phylogenomics, reticulation, and biogeographical history of ElaeagnaceaeWei Gu, Ting Zhang, Shui-Yin Liu, et al.
Journal of Integrative Plant Biology|September 19, 2024
An integrative framework reveals widespread gene flow during the early radiation of oaks and relatives in Quercoideae (Fagaceae)Shui-Yin Liu, Ying-Ying Yang, Qin Tian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxelU A Nitz, O Gluz, M Christgen, et al.
Pageof 19